---
figid: PMC4041068__nihms-580585-f0002
figlink: /pmc/articles/PMC4041068/figure/F2/
number: FIG. 2
caption: Normal activation of MAPK pathway and pathway response to RAF inhibition.
  a Normal activation of the wild-type cell RAS–RAF–MEK–ERK pathway promotes cell
  growth. b Mutations of the MAPK pathway, especially those of oncogenic BRAFV600E
  in melanoma, result in enhanced signaling in the MAPK pathway and eventual tumor
  formation and growth. In the presence of a BRAF inhibitor that blocks BRAF, MEK–
  ERK signaling in BRAFV600E mutant cells is suppressed, causing tumor shrinkage.
  RTK receptor tyrosine kinase (e.g., KIT, FLT2, PDGF, VEGF), RAS rat sarcoma, RAF
  rapidly accelerated fibrosarcoma, MEK MAPK/ERK kinase, ERK extracellular signal–
  regulated kinase
pmcid: PMC4041068
papertitle: The GIST of Targeted Therapy for Malignant Melanoma.
reftext: Danielle M. Bello, et al. Ann Surg Oncol. ;21(6):2059-2067.
pmc_ranked_result_index: '6890'
pathway_score: 0.9639091
filename: nihms-580585-f0002.jpg
figtitle: Normal activation of MAPK pathway and pathway response to RAF inhibition
year: ''
organisms: Homo sapiens
ndex: 27ee55ec-ded6-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4041068__nihms-580585-f0002.html
  '@type': Dataset
  description: Normal activation of MAPK pathway and pathway response to RAF inhibition.
    a Normal activation of the wild-type cell RAS–RAF–MEK–ERK pathway promotes cell
    growth. b Mutations of the MAPK pathway, especially those of oncogenic BRAFV600E
    in melanoma, result in enhanced signaling in the MAPK pathway and eventual tumor
    formation and growth. In the presence of a BRAF inhibitor that blocks BRAF, MEK–
    ERK signaling in BRAFV600E mutant cells is suppressed, causing tumor shrinkage.
    RTK receptor tyrosine kinase (e.g., KIT, FLT2, PDGF, VEGF), RAS rat sarcoma, RAF
    rapidly accelerated fibrosarcoma, MEK MAPK/ERK kinase, ERK extracellular signal–
    regulated kinase
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - MAP2K1
  - MAPK1
  - BRAF
  - ARAF
  - MAPK3
  - MAP2K2
  - KRAS
  - NRAS
  - HRAS
  - RAF1
genes:
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: BRAF
  entrez: '673'
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: ARAF
  entrez: '369'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: RAF1
  entrez: '5894'
chemicals: []
diseases: []
---
